British Journal of Haematology - 138 (2) – Julho (2ª quinzena)
Images in Haematology
Bone marrow lipofuscin in a patient with acute myeloid leukaemia and extensive marrow necrosis
Ioannis Giannoutsos and David Rosenfeld
p. 129–129
White blood cell changes in hyperthermia
Patrick C.J. Ward, Robert W. McKenna and Steven H.Kroft
p. 130–130
Reviews
The management and outcome of chronic graft-versus-host disease
Christopher J. Fraser and K. Scott Baker
p. 131–145
Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies
Tjakiena Henriette Levenga and Johanna N. H. Timmer-Bonte
p. 146–152
Annotation
A strategic framework for novel drug development in multiple myeloma
Kenneth C. Anderson, Alison L. Hannah, Richard Pazdur and Ann T. Farrell
p. 153–159
Haematological Malignancy
Targeting NF-κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth
Michel Jourdan, Jérôme Moreaux, John De Vos, Dirk Hose, Karène Mahtouk, Matthieu Abouladze, Nicolas Robert, Marion Baudard, Thierry Rème, Angela Romanelli, Hartmut Goldschmidt, Jean-François Rossi, Michel Dreano and Bernard Klein
p. 160–168
Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish
Hui Feng, David M. Langenau, Jennifer A. Madge, Andre Quinkertz, Alejandro Gutierrez, Donna S. Neuberg, John P. Kanki and A. Thomas Look
p. 169–175
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3
Bart Barlogie, Elias Anaissie, Frits van Rhee, Jeffrey Haessler, Klaus Hollmig, Mauricio Pineda-Roman, Michele Cottler-Fox, Abid Mohiuddin, Yazan Alsayed, Guido Tricot, Vanessa Bolejack, Maurizio Zangari, Joshua Epstein, Nathan Petty, Douglas Steward, Bonnie Jenkins, Jennifer Gurley, Ellen Sullivan, John Crowley and John D. Jr Shaughnessy
p. 176–185
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients
Marino Clavio, Luana Vignolo, Alessandra Albarello, Riccardo Varaldo, Ivana Pierri, Gioacchino Catania, Manuela Balocco, Gianluca Michelis, Maurizio Miglino, Annunziata Manna, Enrico Balleari, A. Michele Carella, Mario Sessarego, Maria Teresa Van Lint, Andrea Bacigalupo and Marco Gobbi
p. 186–195
Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias
Kajsa Paulsson, Tord Jonson, Ingrid Øra, Tor Olofsson Ioannis Panagopoulos and Bertil Johansson
p. 196–201
Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders
Yasmine Sebti, Amélie Le Maux, Frédéric Gros, Sophie De Guibert, Céline Pangault, Nathalie Rouas-Freiss, Marc Bernard and Laurence Amiot
p. 202–212
Biphenotypic acute leukaemia: a case series
Ahmed Aribi, Carlos Bueso-Ramos, Eli Estey, Zeev Estrov, Susan O'Brien, Francis Giles, Stefan Faderl, Deborah Thomas, Partow Kebriaei, Guillermo Garcia-Manero, Sherry Pierce, Jorge Cortes, Hagop Kantarjian and Farhad Ravandi
p. 213–216
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia
Ludger Sellmann, Stefan Gesk, Christoph Walter, Matthias Ritgen, Lana Harder, José I. Martín-Subero, Roland Schroers, Dörte Siemer, Holger Nückel, Martin J.S. Dyer, Ulrich Dührsen, Reiner Siebert, Jan Dürig and Ralf Küppers
p. 217–220
Platelets, Haemostasis and Thrombosis
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin
Emanuela Falcinelli, Silvia Giannini, Enrico Boschetti and Paolo Gresele
p. 221–230
Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter
Mathieu Garand, Nazareth Bastajian, Michael E. Nesheim, Michael B. Boffa and Marlys L. Koschinsky
p. 231–244
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP
Lemke K. Page, Bethan Psaila, Drew Provan, J. Michael Hamilton, Julian M. Jenkins, Andrew S. Elish, Martin L. Lesser and James B. Bussel
p. 245–248
Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance
Davide Rossi, Lorenzo De Paoli, Silvia Franceschetti, Daniela Capello, Chiara Vendramin, Monia Lunghi, Annarita Conconi, Corrado Magnani and Gianluca Gaidano
p. 249–252
Red Cells and Iron
Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53
Orly Weizer-Stern, Konstantin Adamsky, Ofer Margalit, Osnat Ashur-Fabian, David Givol, Ninette Amariglio and Gideon Rechavi
p. 253–262
The linear effects of α-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease
Nisha Vasavda, Stephan Menzel, Sheila Kondaveeti, Emma Maytham, Moji Awogbade, Sybil Bannister, Juliette Cunningham, Andrew Eichholz, Yvonne Daniel, Iheanyi Okpala, Tony Fulford and Swee Lay Thein
p. 263–270
Correspondence
Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion
Sa A. Wang, Gang Yue, Lloyd Hutchinson, Marie L. Landry, Robert P. Hasserjian, Suyang Hao, Naomi Galili, Azra Raza and Bruce A. Woda
p. 271–275
A ‘pre-induction course’ with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia
Simon Daenen, Gustaaf W. van Imhoff, Joost T.M. de Wolf, Edo Vellenga, Eva van den Berg-de Ruiter and Hanneke C. Kluin-Nelemans
p. 275–277
|
